Loss of histone deacetylases 1 and 2 in hepatocytes impairs murine liver regeneration through Ki67 depletion

Hepatology

Volumn 58, Issue 6, 2013, Pages 2089-2098

  Xia, Jie ^a,b   Zhou, Yongjie ^a   Ji, Hongjie ^a   Wang, Yujia ^a   Wu, Qiong ^a   Bao, Ji ^b,c   Ye, Feng ^c   Shi, Yujun ^a,b   Bu, Hong ^a,b,c  

^a BEIJING HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CARBON TETRACHLORIDE; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; KI 67 ANTIGEN; HDAC1 PROTEIN, MOUSE; HDAC2 PROTEIN, MOUSE; MKI67 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INACTIVATION; GENE INACTIVATION; GENE LOSS; GENE REPRESSION; GENE SILENCING; GENOTYPE; IMMUNOREACTIVITY; LIVER CANCER; LIVER CELL; LIVER REGENERATION; LIVER TOXICITY; MALE; MITOSIS; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; DEFICIENCY; INTOXICATION; KNOCKOUT MOUSE; LIVER RESECTION; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE POISONING; CELL LINE, TUMOR; DOWN-REGULATION; HEPATECTOMY; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; KI-67 ANTIGEN; LIVER REGENERATION; MALE; MICE; MICE, KNOCKOUT; MITOSIS;

EID: 84888292973     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26542     Document Type: Article

References (36)

1. Marks PA, Miller T, Richon VM. Histone deacetylases. Curr Opin Pharmacol 2003;3:344-351.
2. Denis M, Vincent C. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 2008;25:183-189.
3. Brunmeir R, Lagger S, Seiser C. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol 2009;53:275-289.
4. Wang AG, Kim SU, Lee SH, Kim SK, Seo SB, Yu DY, et al. Histone deacetylase 1 contributes to cell cycle and apoptosis. Biol Pharm Bull 2005;28:1966-1970.
5. Mannaerts I, Nuytten NR, Rogiers V, Vanderkerken K, van Grunsven LA, Geerts A. Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology 2010;51:603-614.
6. Prince HM, Bishton MJ, Harrison SJ. Clinical studies of histone deacetylase inhibitors. Clin Cancer Res 2009;15:3958-3969.
7. Marks PA, Xu WS. Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 2009;107:600-608.
8. Yang XJ, Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007;26:5310-5318.
9. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev 2009;10:32-42.
10. Wilting RH, Yanover E, Heideman MR, Jacobs H, Horner J, vander Torre J, et al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J 2010;29:2586-2597.
11. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 2010;24:455-469.
12. Ji P, Yeh V, Ramirez T, Murata-Hori M, Lodish HF. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematologica 2010;95:2013-2021.
13. Noh JH, Jung KH, Kim JK, Eun JW, Bae HJ, Xie HJ, et al. Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. PLoS One 2011;6:e28103.
14. Xie HJ, Noh JH, Kim JK, Jung KH, Eun JW, Bae HJ, et al. HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. PLoS One 2012;7:e34265.
15. Kaimori A, Potter JJ, Choti M, Ding Z, Mezey E, Koteish AA. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. Hepatology 2010;52:1033-1045.
16. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006;6:38-51.
17. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
18. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
19. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004;39:1477-1487.
20. Wang GL, Salisbury E, Shi X, Timchenko L, Medrano EE, Timchenko NA. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice. J Biol Chem 2008;283:26169-26178.
21. Wang GL, Salisbury E, Shi X, Timchenko L, Medrano EE, Timchenko NA. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPbeta. J Biol Chem 2008;283:26179-26187.
22. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 2002;21:2672-2681.
23. Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T, et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 2007;13:324-331.
24. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 2009;12:829-838.
25. Boyce, S, Harrison D. A detailed methodology of partial hepatectomy in the mouse. Lab Anim (NY) 2008;37:529-532.
26. Shukla V, Cuenin C, Dubey N, Herceg Z. Loss of histone acetyltransferase cofactor transformation/transcription domain-associated protein impairs liver regeneration after toxic injury. Hepatology 2011;53:954-963.
27. Hans F, Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001;20:3021-3027.
28. Hirota T, Lipp JJ, Toh BH, Peters JM. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 2005;438:1176-1180.
29. Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, Newton K, et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007;448:811-816.
30. Jackman M, Lindon C, Nigg EA, Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Boil 2003;5:143-148.
31. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GT. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. Hepatology 2003;18:4-12.
32. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-322.
33. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-522.
34. Sueishi M, Takagi M, Yoneda Y. The Forkhead-associated domain of Ki-67 antigen interacts with the novel kinesin-like protein Hklp2. J Biol Chem 2000;275:28888-28892.
35. Takag M, Sueishi M, Saiwaki T, Kametaka A, Yoneda Y. A novel nucleolar protein, NIFK, interacts with the forkhead associated domain of Ki-67 antigen in mitosis. J Biol Chem 2001;276:25386-25391.
36. Ramji DP, Foka V. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002;365:561-575.